drugset / Trial / NCT01311674
Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)
RandomizedParallel-groupOpen-labelOther
Summary
Hepatitis B Virus Antibody Booster Program
Timeline
- Start
- 2009-09
- Primary completion
- 2011-03-11
- Completion
- 2011-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis B vaccine | Vaccine | 20 ug | — |
| Subject | Hepatitis B vaccine | Vaccine | 40 ug | — |
Indications
No indication recorded.